The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure
Open accessAbstract
To assess the efficacy of a multifactorial educational intervention carried out by a pharmacist in patients with heart failure (HF). A randomized, prospective, open clinical trial in patients admitted for HF. The patients assigned to the intervention group received information about the disease, drug therapy, diet education, and active telephone follow-up. Visits were completed at 2, 6, and 12 months. Hospital re-admissions, days of hospital stay, treatment compliance, satisfaction with the care received, and quality of life (EuroQol) were evaluated; a financial study was conducted in order to assess the possible impact of the program. The intervention was performed by the pharmacy department in coordination with the cardiology unit. 134 patients were included, with a mean age of 75 years and a low educational level. The patients of the intervention group had a higher level of treatment compliance than the patients in the control group. At 12 months of follow-up, 32.9% fewer patients in the intervention group were admitted again vs. the control group. The mean days of hospital stay per patient in the control group were 9.6 (SD = 18.5) vs. 5.9 (SD = 14.1) in the intervention group. No differences were recorded in quality of life, but the intervention group had a higher score in the satisfaction scale at two months [9.0 (SD = 1.3) versus 8.2 (SD = 1.8) p = 0.026]. Upon adjusting a Cox survival model with the ejection fraction, the patients in the intervention group had a lower risk of re-admission (Hazard ratio 0.56; 95% CI: 0.32-0.97). The financial analysis evidenced savings in hospital costs of € 578 per patient that were favorable to the intervention group. Postdischarge pharmaceutical care allows for reducing the number of new admissions in patients with heart failure, the total days of hospital stay, and improves treatment compliance without increasing the costs of care. Valorar la eficacia de una intervención educative multifactorial realizada por un farmacéutico en pacientes con insuficiencia cardiaca (IC). Ensayo clínico aleatorizado, prospectivo, abierto, en pacientes ingresados por IC. Los pacientes asignados al grupo intervención recibieron información sobre la enfermedad, el tratamiento farmacológico, educación dietética y seguimiento telefónico activo. Se realizaron visitas a los 2, 6 y 12 meses. Se evaluaron los reingresos hospitalarios, días de hospitalización, cumplimiento terapéutico, satisfacción con la atención recibida y calidad de vida (EuroQol); se realizó un estudio económico para valorar el possible impacto del programa. La intervención la efectuó el servicio de farmacia en coordinación con la unidad de cardiología. Se han incluido 134 pacientes, de edad media 75 años, nivel de estudios bajo. Los pacientes del grupo intervención presentaron un mayor nivel de adherencia al tratamiento que los pacientes del grupo control. A los 12 meses de seguimiento, los pacientes del grupo intervención reingresaron un 32,9% menos que los del grupo control. El promedio de días de hospitalización por paciente en el grupo control fue de 9,6 (DE = 18,5) frente a 5,9 (DE = 14,1) del grupo intervención. No se registraron diferencias en la calidad de vida, pero el grupo intervención presentó mayor puntuación en la escala de satisfacción a los dos meses [9,0 (DE = 1,3) vs. 8,2 (DE = 1,8) p = 0,026]. Al ajustar un modelo de supervivencia de Cox con la fracción de eyección, los pacientes del grupo intervención presentaron un menor riesgo de reingreso (Hazard ratio 0,56; IC95%: 0,32-0,97). El análisis económico evidenció un ahorro en gastos hospitalarios de 578 € por paciente favorable al grupo intervención. La atención farmacéutica al alta hospitalaria permite reducir el número de reingresos en pacientes con insuficiencia cardiaca, los días totales de hospitalización y mejora la adherencia al tratamiento sin aumentar los costes de la atención.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review
McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002) · JAMA · doi:10.1001/jama.288.22.2868 · Cited by 1,176
Cited by
Viswanathan, M., Golin, C. E., Jones, C. D., Ashok, M., Blalock, S. J., Wines, R. C. M., Coker-Schwimmer, E. J. L., Rosen, D. L., Sista, P., & Lohr, K. N. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-11-201212040-00538 · Cited by 754
Feltner, C., Jones, C. D., Cené, C. W., Zheng, Z.-J., Sueta, C. A., Coker-Schwimmer, E. J. L., Arvanitis, M., Lohr, K. N., Middleton, J. C., & Jonas, D. E. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0083 · Cited by 681
Ruppar, T. M., Cooper, P. S., Mehr, D. R., Delgado, J. M., & Dunbar‐Jacob, J. M. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002606 · Cited by 415
Van Spall, H. G. C., Rahman, T., Mytton, O., Ramasundarahettige, C., Ibrahim, Q., Kabali, C., Coppens, M., Brian Haynes, R., & Connolly, S. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.765 · Cited by 381
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns
Nkansah, N., Mostovetsky, O., Yu, C., Chheng, T., Beney, J., Bond, C. M., & Bero, L. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000336.pub2 · Cited by 343
Metadata
- Authors
- López Cabezas, C., Falces Salvador, C., Cubí Quadrada, D., Arnau Bartés, A., Ylla Boré, M., Muro Perea, N., & Homs Peipoch, E.
- Venue
- Farmacia Hospitalaria
- Publisher
- Elsevier BV
- Published
- 2006
- Volume
- 30
- Issue
- 6
- Pages
- 328-342
- ISSN
- 1130-6343 (ISSN-L)
- OpenAlex
- W2124234445
- Cited by
- 182
- References
- 2
- FWCI
- 2.84
- Type
- journal article
- Language
- es
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure. https://app.cochat.ai/papers/10.1016/s1130-6343(06)74004-1
- The paper
- López Cabezas, C., Falces Salvador, C., Cubí Quadrada, D., Arnau Bartés, A., Ylla Boré, M., Muro Perea, N., & Homs Peipoch, E. (2006). Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure. Farmacia Hospitalaria. https://doi.org/10.1016/s1130-6343(06)74004-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.